Skip to main content

QuidelOrtho Corp

QDEL
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001906324

No open-market purchases or sales by QuidelOrtho Corp insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q3 2026, worth $863.5M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 18, 2026
$656.6M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, 0 vs. previous quarter
242
13F valueReported value at the end of Q3 2026
$863.5M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$2.73B
−1.9% year over year
Net income, FY2025
-$1.13B
No comparable prior period
Free cash flow, FY2025
-$83.0M
No comparable prior period
Revenue, Q3 FY2026
$618.9M
−11.6% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $1.13B (41.5% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
14.5M
Shares sold short
Change
+1.47M
+11.3% vs. previous
Days to cover
7.60
At average daily volume

Superinvestors holding QDEL, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding QDEL at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by QuidelOrtho Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 19, 2026 (view filing)Feb 136 daysBusky Joseph MChief Financial OfficerPPurchase+3.37K$23.66+$79.7K+48.7%10.3K afterAmended
Feb 13, 2026 (view filing)Feb 13Same dayBlaser Brian JPresident and CEOPPurchase+10.5K$23.59+$248.6K+35.7%40.1K after
Feb 13, 2026 (view filing)Feb 13Same dayStrobeck MatthewDirectorPPurchase+10.0K$23.96+$239.6K+56.3%27.8K after
Dec 10, 2025 (view filing)Dec 10Same dayRhoads Ann DDirectorPPurchase+750$28.28+$21.2K+5.3%15.0K after
Dec 1, 2025 (view filing)Nov 265 daysWilkins Joseph D Jr.DirectorPPurchase+370$27.96+$10.3K+3.2%11.9K after
Nov 25, 2025 (view filing)Nov 241 dayBusky Joseph MChief Financial OfficerPPurchase+4.77K$26.06+$124.3K+221.9%6.92K after
Nov 25, 2025 (view filing)Nov 25Same dayWidder Kenneth JDirectorSSale−4.03K$27.81−$112.0K−9.8%37.1K after
Nov 24, 2025 (view filing)Nov 213 daysPolan Mary Lake PH DDirectorPPurchase+1.00K$22.43+$22.4K+8.6%12.6K after
Nov 20, 2025 (view filing)Nov 191 dayBlaser Brian JPresident and CEOPPurchase+23.5K$21.34+$501.5K+389.5%29.5K after
Dec 13, 2024 (view filing)Dec 112 daysBlaser Brian JPresident and CEOPPurchase+6.03K$41.42+$249.9KNew position6.03K after

Top 10 13F holders, Q3 2026

See all 242 holders

The largest institutional positions in QuidelOrtho Corp at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding QDEL in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.11,143,003$117.4M0.00%−59,520−0.5%Reduced
Newtyn Management, LLC5,342,283$56.3M7.72%−1,282,717−19.4%Reduced
FMR LLC3,950,168$41.6M0.00%−3,413,528−46.4%Reduced
American Century Companies Inc3,926,634$41.4M0.02%+619,555+18.7%Added
Vanguard Portfolio Management LLC3,635,778$38.3M0.00%−499,686−12.1%Reduced
Invesco Ltd.3,604,814$38.0M0.00%+131,382+3.8%Added
Rubric Capital Management LP3,133,148$33.0M0.31%−173,133−5.2%Reduced
State Street Corp3,026,630$31.9M0.00%+47,991+1.6%Added
Vanguard Capital Management LLC3,015,589$31.8M0.00%−54,465−1.8%Reduced
Neuberger Berman Group LLC2,949,874$31.1M0.02%−584,745−16.5%Reduced

Holders of 5% or more of QDEL

See all 8 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of QuidelOrtho Corp.

Largest holders of QDEL from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A14.80%10.0M shares+2.30 ppfrom 12.50%Oct 7, 20243 filingsJul 17, 2025SEC
Newtyn Management, LLC13G/A7.80%5.34M shares−1.90 ppfrom 9.70%May 6, 20264 filingsNov 16, 2026SEC
Vanguard Portfolio Management LLC13G6.00%4.09M sharesNewApr 29, 20261 filingApr 29, 2026SEC
FMR LLC13G/A5.80%3.95M shares−5.70 ppfrom 11.50%Nov 5, 20255 filingsOct 7, 2026SEC
American Century Investment Management Inc13G5.70%3.93M sharesNewNov 16, 20261 filingNov 16, 2026SEC

4 members of Congress reported 14 trades in QuidelOrtho Corp since 2020. Newest filings:

  1. Daniel S. Goldman

    House · NY · Aug 13, 2023

    Sell$1K-$15K

  2. Tom Malinowski

    House · NJ · Jun 23, 2021

    Buy$15K-$50K

  3. Tom Malinowski

    House · NJ · Jun 12, 2021

    Sell$1K-$15K

  4. Tom Malinowski

    House · NJ · Apr 10, 2021

    Sell$1K-$15K

  5. Tom Malinowski

    House · NJ · Apr 10, 2021

    Sell$15K-$50K